Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.74% slid 2.13% to $90.36 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.57% falling 1.30% to 14,154.02 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.14% falling 0.89% to 34,715.39. This was the stock's seventh consecutive day of losses. Novavax Inc. closed $241.32 below its 52-week high ($331.68), which the company reached on February 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL -1.18% fell 3.24% to $20.60, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV +2.59% fell 1.08% to $1.83, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +4.73% fell 3.50% to $31.11. Trading volume (7.5 M) eclipsed its 50-day average volume of 5.8 M.